This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Free Online Activities

Initiatives to Promote the Discovery of Drugs to Improve Cognitive Function in Severe Mental Illness

Stephen R. Marder

Published: July 14, 2006

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders



Article Abstract


Current pharmacotherapy for treating schizophrenia islimited because treatments focus on positive symptom control rather thanimproving social and vocational function and few new treatments have beendeveloped in the past 50 years. To better facilitate the development oftreatments for the cognitive impairments in schizophrenia and for improvingfunctional outcome in schizophrenia, the Measurement and Treatment Research toImprove Cognition in Schizophrenia (MATRICS) program was established. TheMATRICS program has developed a way of measuring outcome in trials ofcognition-enhancing drugs, provided guidelines for doing studies ofcognition-enhancing drugs, and lookedat the most promising molecular targets for improving cognition using differentkinds of pharmacologic agents. By focusing on cognitive impairments and negativesymptoms, the functional outcomes of patients with schizophrenia may beimproved.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 67

Quick Links: Cognition , Neurologic and Neurocognitive

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Skeletal and Dental Fractures Associated With Electroconvulsive Therapy

Recent data suggest the risk of skeletal or dental fracture with ECT may be as low as...

Read More...